Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$2.16 - $4.06 $0 - $0
0 New
0 $0
Q2 2024

Jul 23, 2024

SELL
$4.18 - $7.35 $1,220 - $2,146
-292 Closed
0 $0
Q1 2023

May 15, 2023

SELL
$6.62 - $9.57 $3,250 - $4,698
-491 Reduced 62.71%
292 $2,000
Q4 2022

Jan 30, 2023

SELL
$8.78 - $12.47 $24,575 - $34,903
-2,799 Reduced 78.14%
783 $0
Q3 2022

Nov 15, 2022

SELL
$8.96 - $14.7 $28,591 - $46,907
-3,191 Reduced 47.11%
3,582 $40,000
Q2 2022

Aug 09, 2022

BUY
$6.52 - $13.24 $44,159 - $89,674
6,773 New
6,773 $86,000
Q1 2022

May 09, 2022

BUY
$6.2 - $7.87 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$5.13 - $7.89 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$4.89 - $7.82 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.61 - $6.83 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$6.19 - $16.0 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$3.9 - $11.25 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$1.4 - $3.87 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$1.2 - $1.99 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020

BUY
$1.74 - $2.1 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.66 - $2.2 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$1.63 - $2.2 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$2.1 - $3.07 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$2.7 - $3.65 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.95 - $3.27 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$2.94 - $3.23 $0 - $0
0 New
0 $0

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $12.3M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.